Schnitzler's syndrome: Successful treatment of two patients using thalidomide [9]

British Journal of Dermatology

Volumn 148, Issue 3, 2003, Pages 601-602

  Worm, M ^a   Kolde, G ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; COLCHICINE; CORTICOSTEROID; CYCLOSPORIN A; CYTOKINE; DAPSONE; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 6; NONSTEROID ANTIINFLAMMATORY AGENT; THALIDOMIDE; TUMOR NECROSIS FACTOR ALPHA;

BLOOD ANALYSIS; BONE PAIN; CASE REPORT; CHRONIC URTICARIA; CLINICAL FEATURE; DISEASE COURSE; DOWN REGULATION; DRUG EFFICACY; DRUG INHIBITION; DRUG TOLERABILITY; FEVER; GAMMOPATHY; HISTOPATHOLOGY; HUMAN; INFLAMMATORY DISEASE; LABORATORY TEST; LETTER; LYMPHADENOPATHY; MONOTHERAPY; OSTEOSCLEROSIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SCHNITZLER SYNDROME; TREATMENT OUTCOME;

HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-6; SCHNITZLER SYNDROME; THALIDOMIDE; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0037365912     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2003.05209_9.x     Document Type: Letter

References (9)

1. Schnitzler L, Schubert B, Boasson M et al. Urticaire chronique, lésions osseuses, macroglobulinémie IgM: maladie de Waldenström? Bull Soc Fr Dermatol Syphiligr 1974; 81: 663-7.
2. Lipsker D, Veran Y, Grunenberger F et al. The Schnitzler syndrome. Four new cases and review of the literature. Medicine (Baltimore) 2001; 80: 37-44.
3. Puddu P, Cianchini G, Girardelli CR et al. Schnitzler's syndrome: report of a new case and review of the literature. Clin Exp Rheumatol 1997; 15: 91-5.
4. Allen BR, Thalidomide. Br J Dermatol 2001; 144: 225-8.
5. Calabrese L, Fleischer AB Jr. Thalidomide: current and potential clinicai applications. Am J Med 2000; 108: 487-95.
6. Tseng S, Pak G, Washenik K et al. Rediscovering thalidomide: a review of its mechanism of action, side effects, and potential uses. J Am Acad Dermatol 1996; 5: 969-79.
7. Corral LG, Kaplan G. Immunomodulation by thalidomide and thalidomide analogues. Ann Rheum Dis 1999; 58 (Suppl. 1): 107-13.
8. Corral LG, Haslett PA, Muller GW et al. Differential cytokine modulation and T cell activation by two distinct classes of thalidomide analogues that are potent inhibitors of TNF-alpha. J Immunol 1999; 163: 380-6.
9. de Kleijn EM, Telgt D, Laan R. Schnitzler's syndrome presenting as fever of unknown origin (FUO). The role of cytokines in its systemic features. Neth J Med 1997; 51: 140-2.